| Ryan Herring, | |
|
101 The City Dr S, Orange, CA 92868-3201 | |
| (714) 456-7890 | |
| Not Available |
| Full Name | Ryan Herring |
|---|---|
| Gender | Male |
| Speciality | Preventive Medicine |
| Experience | 6 Years |
| Location | 101 The City Dr S, Orange, California |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1255823993 | NPI | - | NPPES |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Uc Regents | 7416869516 | 205 |
News Archive
Research!America and the Rita Allen Foundation are pleased to announce the recipients of the 2021 Civic Engagement Microgrant Initiative. Now
CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it filed an emergency motion for a preliminary injunction against Medafor, Inc. in the United States District Court for the Northern District of Georgia, Atlanta division. CryoLife contends that Medafor is improperly attempting to terminate the exclusive distribution agreement ("EDA") between the parties, and CryoLife has requested that the Court enjoin Medafor from proceeding with the termination.
Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.
In 3-year follow-up after bariatric surgery, substantial weight loss was observed among individuals who were severely obese, with most of the change occurring during the first year; however, there was variability in the amount of weight loss, as well as in diabetes, blood pressure, and lipid outcomes, according to a study published online by JAMA.
› Verified 9 days ago
| Entity Name | Uc Regents |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1760430847 PECOS PAC ID: 7416869516 Enrollment ID: O20031118000906 |
News Archive
Research!America and the Rita Allen Foundation are pleased to announce the recipients of the 2021 Civic Engagement Microgrant Initiative. Now
CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it filed an emergency motion for a preliminary injunction against Medafor, Inc. in the United States District Court for the Northern District of Georgia, Atlanta division. CryoLife contends that Medafor is improperly attempting to terminate the exclusive distribution agreement ("EDA") between the parties, and CryoLife has requested that the Court enjoin Medafor from proceeding with the termination.
Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.
In 3-year follow-up after bariatric surgery, substantial weight loss was observed among individuals who were severely obese, with most of the change occurring during the first year; however, there was variability in the amount of weight loss, as well as in diabetes, blood pressure, and lipid outcomes, according to a study published online by JAMA.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ryan Herring, 2139 Elements Way, Irvine, CA 92612-1533 Ph: (309) 251-8171 | Ryan Herring, 101 The City Dr S, Orange, CA 92868-3201 Ph: (714) 456-7890 |
News Archive
Research!America and the Rita Allen Foundation are pleased to announce the recipients of the 2021 Civic Engagement Microgrant Initiative. Now
CryoLife, Inc. (NYSE: CRY), an implantable biological medical device and cardiovascular tissue processing company, announced today that it filed an emergency motion for a preliminary injunction against Medafor, Inc. in the United States District Court for the Northern District of Georgia, Atlanta division. CryoLife contends that Medafor is improperly attempting to terminate the exclusive distribution agreement ("EDA") between the parties, and CryoLife has requested that the Court enjoin Medafor from proceeding with the termination.
Researchers at Mayo Clinic have identified a genetic promoter of cancer that drives a major form of lung cancer.
In 3-year follow-up after bariatric surgery, substantial weight loss was observed among individuals who were severely obese, with most of the change occurring during the first year; however, there was variability in the amount of weight loss, as well as in diabetes, blood pressure, and lipid outcomes, according to a study published online by JAMA.
› Verified 9 days ago